[go: up one dir, main page]

SA98190764B1 - مثبطات التخليق الحيوي لبروستاجلاندين اندوبيروكسيد hسينثار - Google Patents

مثبطات التخليق الحيوي لبروستاجلاندين اندوبيروكسيد hسينثار Download PDF

Info

Publication number
SA98190764B1
SA98190764B1 SA98190764A SA98190764A SA98190764B1 SA 98190764 B1 SA98190764 B1 SA 98190764B1 SA 98190764 A SA98190764 A SA 98190764A SA 98190764 A SA98190764 A SA 98190764A SA 98190764 B1 SA98190764 B1 SA 98190764B1
Authority
SA
Saudi Arabia
Prior art keywords
alkyl
aryl
cycloalkyl
amino
phenyl
Prior art date
Application number
SA98190764A
Other languages
Arabic (ar)
English (en)
Inventor
انور باشا
جيفري جيه رود
مايكل اي كورت
لورانس ايه بلاك
هواكنج ليو
تيودوزيج كولاسا
كاثرين ام مكارتي
مينا في باتل
Original Assignee
ابوت لابوراتوريز
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ابوت لابوراتوريز filed Critical ابوت لابوراتوريز
Publication of SA98190764B1 publication Critical patent/SA98190764B1/ar

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SA98190764A 1997-08-22 1998-11-16 مثبطات التخليق الحيوي لبروستاجلاندين اندوبيروكسيد hسينثار SA98190764B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91702397A 1997-08-22 1997-08-22

Publications (1)

Publication Number Publication Date
SA98190764B1 true SA98190764B1 (ar) 2006-08-06

Family

ID=25438243

Family Applications (1)

Application Number Title Priority Date Filing Date
SA98190764A SA98190764B1 (ar) 1997-08-22 1998-11-16 مثبطات التخليق الحيوي لبروستاجلاندين اندوبيروكسيد hسينثار

Country Status (8)

Country Link
EP (1) EP1007515A1 (fr)
BR (1) BR9812127A (fr)
CA (1) CA2299300C (fr)
CO (1) CO4970740A1 (fr)
SA (1) SA98190764B1 (fr)
TW (1) TWI232216B (fr)
WO (1) WO1999010331A1 (fr)
ZA (1) ZA987555B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6525053B1 (en) * 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
AU738595B2 (en) 1997-11-19 2001-09-20 Kowa Co., Ltd. Novel pyridazine derivatives and medicines containing the same as effective ingredients
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
AU756275B2 (en) 1998-08-14 2003-01-09 Nihon Nohyaku Co., Ltd. Pyridazinone derivatives
HUP0105248A3 (en) * 1998-10-27 2002-09-30 Abbott Lab Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−3−オン誘導体及びこれを含有する医薬
PT1175214E (pt) 1999-12-08 2005-04-29 Pharmacia Corp Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
CA2393724A1 (fr) 1999-12-23 2001-06-28 Nitromed, Inc. Inhibiteurs de cyclooxygenase-2 nitroses et nitrosyles, compositions et procedes d'utilisation
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
ITMI20010733A1 (it) 2001-04-05 2002-10-05 Recordati Chem Pharm Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP2005519895A (ja) * 2002-01-18 2005-07-07 ファルマシア・コーポレーション P38阻害剤としての置換ピリダジノン
WO2004002420A2 (fr) 2002-06-28 2004-01-08 Nitromed, Inc. Inhibiteurs a selectivite cyclooxygenase-2 nitrosiles et/ou nitroses contenant une oxime et/ou une hydrazone, compositions et methodes d'utilisation correspondantes
EP1604984A1 (fr) 2003-03-18 2005-12-14 Kowa Co., Ltd. Derive de phenylpyridazine soluble dans l'eau et medicament contenant ce derive
PL1534305T3 (pl) 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
WO2005007632A1 (fr) * 2003-07-18 2005-01-27 Pharmacia Corporation Pyridazinones substituees utiles comme inhibiteurs de p38
WO2005121104A1 (fr) 2004-06-09 2005-12-22 Sumitomo Chemical Company, Limited Composé pyridazine et utilisation de celui-ci
EP1775290B1 (fr) 2004-06-28 2010-11-17 Sumitomo Chemical Company, Limited Compose de pyridazine et son utilisation
EP1928454B1 (fr) 2005-05-10 2014-09-24 Intermune, Inc. Derives du pyridone destines a la modulation du systeme de kinase proteinique active par le stress
BRPI0616655A2 (pt) 2005-10-03 2011-06-28 Ono Pharmaceutical Co composto heterocìclico contendo nitrogênio e aplicação farmacêutica do mesmo
DK1958948T3 (da) 2005-12-07 2011-10-31 Sumitomo Chemical Co Pyridazinforbindelse og anvendelse deraf
WO2007066601A1 (fr) 2005-12-07 2007-06-14 Sumitomo Chemical Company, Limited Compose de pyridazine et son emploi
DE102007008840A1 (de) * 2007-02-23 2008-08-28 Bayer Healthcare Ag Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP)
DE102007008843A1 (de) 2007-02-23 2008-08-28 Bayer Healthcare Ag Verfahren zur Herstellung von 4,5-Dihalogen-2-aryl-2H-pyridazin-3-onen
DE102007008839A1 (de) 2007-02-23 2008-08-28 Bayer Healthcare Ag Verfahren zur Herstellung von 4-(3-Hydroxy-3-methyl-butoxy)-5-[4-(methylsulfonyl)phenyl]-2-arylpyridazin-3(2H)-onen
DE102007020690A1 (de) * 2007-05-03 2008-11-06 Bayer Healthcare Ag Neue amorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-mehtyl-1-butoxy)-6[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP)
DE102007020689A1 (de) 2007-05-03 2008-11-06 Bayer Healthcare Ag Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy-5-[4-methylsulfonyl)phenyl]3/2H)-pyridazinon (FHMP)
MX2010012848A (es) 2008-06-03 2011-03-01 Intermune Inc Compuestos y metodos para tratar trastornos inflamatorios y fibroticos.
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
US9212147B2 (en) 2011-11-15 2015-12-15 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类
JP7096598B2 (ja) 2016-09-07 2022-07-06 トラスティーズ オブ タフツ カレッジ イムノdash阻害剤及びpge2アンタゴニストを用いた併用療法
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009675A1 (fr) * 1987-06-05 1988-12-15 Medicis Corporation Inhibition du metabolisme de l'acide arachidonique
IL115889A0 (en) * 1994-11-14 1996-01-31 Rohm & Haas Pyridazinones and their use as fungicides
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents

Also Published As

Publication number Publication date
CA2299300A1 (fr) 1999-03-04
BR9812127A (pt) 2000-07-18
TWI232216B (en) 2005-05-11
EP1007515A1 (fr) 2000-06-14
CO4970740A1 (es) 2000-11-07
WO1999010331A1 (fr) 1999-03-04
ZA987555B (en) 1999-02-23
CA2299300C (fr) 2007-04-17

Similar Documents

Publication Publication Date Title
SA98190764B1 (ar) مثبطات التخليق الحيوي لبروستاجلاندين اندوبيروكسيد hسينثار
US7115591B2 (en) Prostaglandin endoperoxide H synthase biosynthesis inhibitors
JP3793694B2 (ja) 抗炎症剤としての芳香族複素環化合物
DE69926903T2 (de) Prostaglandin endoperoxyde h synthase biosynthese inhibitoren
CA1254212A (fr) Amines derives, leur sels, procede de preparation et agent anti-ulcereux les contenant
AP648A (en) Indole derivatives useful in the treatment of osteoporosis.
JP2004536845A (ja) サイトカイン媒介疾患の治療方法
MC2010A1 (fr) Pyrroles substitues
SA516371448B1 (ar) مشتقات حلقية غير متجانسة ثنائية الحلقة كمثبطات نطاق برومو
WO2001047890A1 (fr) Quinoline, derives de la quinazoline et medicaments contenant ces substances
SA03240431A (ar) مركبات 3-امينو بيرازول ثلاثية الحلقه تحمل بدائل عند ذرة النتروجين بصفتها مثبطات لمعالجه اضطرابات التكاثر الخلوى
EP1206467A1 (fr) Derives n-heterocycliques sous forme d'inhibiteurs oxyde nitrique synthase
JPH10512555A (ja) サイトカインとして有用なある種の1,4,5−三置換イミダゾール化合物
HU228126B1 (en) Pyran-2-one- and 5,6-dihydro-pyran-2-one derivatives useful for treating hiv- and other retrovirus infections
HU198711B (en) Process for producing mevalolacton, derivatives and pyrazol analogues and pharmaceutical composition containing them
US10328077B2 (en) Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
SA07280131B1 (ar) مشتقات تريازولون
AU2001263874B2 (en) Pyrrole derivatives for treating aids
WO2018124180A1 (fr) Agent antitumoral et inhibiteur de bromodomaine
SA05260282A (ar) مركبات البنزاميد
US5145868A (en) Alkanophenones useful for treating allergies
NL8105652A (nl) Heterocyclische verbindingen.
AU741317B2 (en) Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
JPS60149580A (ja) フラベン及びチオフラベン誘導体、それらの製法、並びにそれらを含む医薬調合物
US20120196915A1 (en) Antitumor 1,2-Diphenylpyrrole Compounds and their Preparation Process